158 related articles for article (PubMed ID: 7495477)
1. Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications.
Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Durkin KP; Boyd MR; Bai R; Hamel E; Schmidt JM; Chapuis JC
Anticancer Drug Des; 1995 Oct; 10(7):529-44. PubMed ID: 7495477
[TBL] [Abstract][Full Text] [Related]
2. Antineoplastic agents 360. Synthesis and cancer cell growth inhibitory studies of dolastatin 15 structural modifications.
Pettit GR; Flahive EJ; Boyd MR; Bai R; Hamel E; Pettit RK; Schmidt JM
Anticancer Drug Des; 1998 Jan; 13(1):47-66. PubMed ID: 9474242
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic agents 365. Dolastatin 10 SAR probes.
Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Boyd MR; Hamel E; Pettit RK; Hogan F; Bai R; Chapuis JC; McAllister SC; Schmidt JM
Anticancer Drug Des; 1998 Jun; 13(4):243-77. PubMed ID: 9627667
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicity.
Bai R; Roach MC; Jayaram SK; Barkoczy J; Pettit GR; Ludueña RF; Hamel E
Biochem Pharmacol; 1993 Apr; 45(7):1503-15. PubMed ID: 8471072
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
Mohammad RM; Varterasian ML; Almatchy VP; Hannoudi GN; Pettit GR; Al-Katib A
Clin Cancer Res; 1998 May; 4(5):1337-43. PubMed ID: 9607595
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity studies with chiral isomers and with segments of the antimitotic marine peptide dolastatin 10.
Bai RL; Pettit GR; Hamel E
Biochem Pharmacol; 1990 Oct; 40(8):1859-64. PubMed ID: 2242019
[TBL] [Abstract][Full Text] [Related]
7. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain.
Bai R; Pettit GR; Hamel E
Biochem Pharmacol; 1990 Jun; 39(12):1941-9. PubMed ID: 2353935
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and X-ray crystal structure of the dolabellaauricularia peptide dolastatin 18.
Pettit GR; Hogan F; Herald DL
J Org Chem; 2004 Jun; 69(12):4019-22. PubMed ID: 15176826
[TBL] [Abstract][Full Text] [Related]
9. Diazonamide A and a synthetic structural analog: disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin.
Cruz-Monserrate Z; Vervoort HC; Bai R; Newman DJ; Howell SB; Los G; Mullaney JT; Williams MD; Pettit GR; Fenical W; Hamel E
Mol Pharmacol; 2003 Jun; 63(6):1273-80. PubMed ID: 12761336
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiproliferative activity of a cyclic analog of dolastatin 10.
Poncet J; Hortala L; Busquet M; Guéritte-Voegelein F; Thoret S; Pierré A; Atassi G; Jouin P
Bioorg Med Chem Lett; 1998 Oct; 8(20):2855-8. PubMed ID: 9873636
[TBL] [Abstract][Full Text] [Related]
11. Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452.
Luesch H; Yoshida WY; Moore RE; Paul VJ; Mooberry SL; Corbett TH
J Nat Prod; 2002 Jan; 65(1):16-20. PubMed ID: 11809057
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of chimeric structures derived from the cytotoxic natural compounds dolastatin 10 and dolastatin 15.
Poncet J; Busquet M; Roux F; Pierré A; Atassi G; Jouin P
J Med Chem; 1998 Apr; 41(9):1524-30. PubMed ID: 9554885
[TBL] [Abstract][Full Text] [Related]
13. Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules.
Bai R; Friedman SJ; Pettit GR; Hamel E
Biochem Pharmacol; 1992 Jun; 43(12):2637-45. PubMed ID: 1632820
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of novel dolastatin 10 analogs.
Miyazaki K; Kobayashi M; Natsume T; Gondo M; Mikami T; Sakakibara K; Tsukagoshi S
Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1706-18. PubMed ID: 8536345
[TBL] [Abstract][Full Text] [Related]
15. A new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft model.
Mohammad RM; Limvarapuss C; Wall NR; Hamdy N; Beck FW; Pettit GR; Al-Katib A
Int J Oncol; 1999 Aug; 15(2):367-72. PubMed ID: 10402249
[TBL] [Abstract][Full Text] [Related]
16. The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domain.
Bai R; Taylor GF; Cichacz ZA; Herald CL; Kepler JA; Pettit GR; Hamel E
Biochemistry; 1995 Aug; 34(30):9714-21. PubMed ID: 7626642
[TBL] [Abstract][Full Text] [Related]
17. Hybrids of the hemiasterlin analogue taltobulin and the dolastatins are potent antimicrotubule agents.
Zask A; Kaplan J; Musto S; Loganzo F
J Am Chem Soc; 2005 Dec; 127(50):17667-71. PubMed ID: 16351096
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytostatic properties of structure-simplified analogs of dolastatin 15.
Hu MK; Huang WS
J Pept Res; 1999 Dec; 54(6):460-7. PubMed ID: 10604591
[TBL] [Abstract][Full Text] [Related]
19. Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell-less mollusc.
Turner T; Jackson WH; Pettit GR; Wells A; Kraft AS
Prostate; 1998 Feb; 34(3):175-81. PubMed ID: 9492845
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Dolastatin 15 mimetic peptoids.
Schmitt J; Bernd M; Kutscher B; Kessler H
Bioorg Med Chem Lett; 1998 Feb; 8(4):385-8. PubMed ID: 9871690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
